Generic Name: formaldehyde
Dosage Form: topical liquid
Forma-Ray
A tinted aqueous perfumed base provides preferable vehicles for the topical application of formalin solution to relieve severe conditions of bromidrosis and hyperhydrosis. This formula is double the strength of Formadon. Formalin solution dries the skin's surface, and makes a very good drying agent after surgery or laser treatment.
2 oz sponge tip plastic bottle and 4 oz plastic bottle.
Formaldehyde (20% of USP strength) formulated in a aqueous perfumed base.
Indications: Antiperspirant for the treatment of hyperhydrosis and bromidrosis. Drying agent for verrucae. Drying agent for post surgical removal of warts or for nonsurgical laser treatment of warts. Directions: Apply to feet twice weekly or as prescribed by a Physician.
Contraindications/Warnings: Avoid frequent use. Avoid frequent use. Avoid contact with eyes or mucous membranes. Do not apply to open wounds. Should signs of irritation develop, medications should be discontinued. Irritates eyes. nose and throat. Keep out of reach of children. For external use only. Harmful if swallowed. Contact your local poison control center immediately. Do not induce vomiting. If conscious, give eight ounce of (240ml) of milk, or water with activated charcoal.
Keep well closed in a cool place.
Forma-Ray formaldehyde liquid | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved drug other | 07/15/2010 |
Labeler - Gordon Laboratories (002333847) |
Registrant - Gordon Laboratories (002333847) |
Establishment | |||
Name | Address | ID/FEI | Operations |
Gordon Laboratories | 002333847 | manufacture |
More Forma-Ray resources
- Forma-Ray Use in Pregnancy & Breastfeeding
- Forma-Ray Support Group
- 0 Reviews · Be the first to review/rate this drug
- Formadon Solution MedFacts Consumer Leaflet (Wolters Kluwer)
No comments:
Post a Comment